← back to search

Nazila Kamaly

Massachusetts Institute of Technology · US
Area of research
Biomaterials · Molecular Biology
Research interest
Research interests include Chemistry, Inflammation, Nanomedicine, Nanocarriers, Drug delivery, and Nanotechnology.
h-index
citations
7,375
works
15
NIH funding
primary concept
email

Recent publications

An innovative and eco-friendly modality for synthesis of highly fluorinated graphene by an acidic ionic liquid: Making of an efficacious vehicle for anti-cancer drug delivery
Applied Surface Science 2020cited by 49position: middledoi
Sericin grafted multifunctional curcumin loaded fluorinated graphene oxide nanomedicines with charge switching properties for effective cancer cell targeting
International Journal of Pharmaceutics 2019cited by 39position: middledoi
Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in <i>Ldlr<sup>−/−</sup></i> Mice
Advanced Healthcare Materials 2017cited by 85position: middledoi
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
Chemical Reviews 2016cited by 2,874position: firstdoi
Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery
Nano Today 2016cited by 608position: middledoi
Nanomedicines for renal disease: current status and future applications
Nature Reviews Nephrology 2016cited by 238position: firstdoi
Annexin A1–containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair
Journal of Clinical Investigation 2015cited by 367position: middledoi
Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice
Science Translational Medicine 2015cited by 354position: middledoi
Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle
Science Translational Medicine 2015cited by 332position: middledoi
Nanomedicines for endothelial disorders
Nano Today 2015cited by 55position: middledoi
Engineered nanomedicine for myeloma and bone microenvironment targeting
Proceedings of the National Academy of Sciences 2014cited by 284position: middledoi
Development of Multinuclear Polymeric Nanoparticles as Robust Protein Nanocarriers
Angewandte Chemie International Edition 2014cited by 141position: middledoi
Development of Therapeutic Polymeric Nanoparticles for the Resolution of Inflammation
Advanced Healthcare Materials 2014cited by 40position: middledoi
Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
Proceedings of the National Academy of Sciences 2013cited by 214position: firstdoi
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Chemical Society Reviews 2012cited by 1,695position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Omid C. Farokhzad · Brigham and Women's Hospital11 papers (2012–2016)Jinjun Shi · Brigham and Women's Hospital4 papers (2014–2017)Suresh Gadde · University of Tennessee at Knoxville3 papers (2013–2015)Gabrielle Fredman · Albany Medical Center Hospital3 papers (2013–2015) · 2 papers (2019–2020)Sepehr Talebian · The University of Sydney2 papers (2019–2020) · 2 papers (2019–2020)Ira Tabas · Columbia University Irving Medical Center2 papers (2013–2015)Edward A. Fisher · Institute for Biomedical Engineering2 papers (2014–2017) · 2 papers (2019–2020)Zahi A. Fayad · Mount Sinai Hospital2 papers (2013–2015) · 2 papers (2019–2020)Jun Wu · Nanjing Agricultural University2 papers (2014–2016)Zeyu Xiao · Massachusetts Institute of Technology2 papers (2012–2014)Mauro Perretti · Queen Mary University of London2 papers (2015–2015)Mehdi Mehrali · Delft University of Technology2 papers (2019–2020)Róbert Langer · Laboratoire d’immunologie intégrative du cancer2 papers (2013–2015) · 2 papers (2019–2020) · 2 papers (2019–2020) · 1 papers (2014–2014)